Lexicon Pharmaceuticals LXRX SEC Filings

NASDAQ LXRX
$2.24 -0.02 (-0.88%)
At close: Sep 4, 2026 · 4:00 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Lexicon Pharmaceuticals, Inc. (LXRX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index